Bio-Rad Laboratories Inc. logo

Bio-Rad Laboratories Inc. (BUWA)

Market Closed
11 Jul, 20:00
XBER XBER
220. 20
+6.7
+3.14%
9.88B Market Cap
- P/E Ratio
0% Div Yield
0 Volume
11.51 Eps
213.5
Previous Close
Day Range
220.2 220.2
Year Range
187.6 351.8
Want to track BUWA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 17 days

Summary

BUWA closed Friday higher at €220.2, an increase of 3.14% from Thursday's close, completing a monthly increase of 8.37% or €17. Over the past 12 months, BUWA stock lost -30.14%.
BUWA is not paying dividends to its shareholders.
The last earnings report, released on May 05, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 30, 2025.
Bio-Rad Laboratories Inc. has completed 5 stock splits, with the recent split occurring on Mar 08, 2002.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on NYSE (USD).

BUWA Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
New Strong Sell Stocks for July 10th

New Strong Sell Stocks for July 10th

BIO, DECK and ELUXY have been added to the Zacks Rank #5 (Strong Sell) List on July 10, 2025.

Zacks | 3 days ago
Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends

Investing in Bio-Rad (BIO)? Don't Miss Assessing Its International Revenue Trends

Explore Bio-Rad's (BIO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks | 2 months ago
BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket

BIO Beats on Q1 Earnings, Lowers '25 View, Stock Up in Aftermarket

Bio-Rad witnesses first-quarter top-line decline in its Life Science segment, primarily due to challenges in the academic research market.

Zacks | 2 months ago

Bio-Rad Laboratories Inc. Dividends

BUWA is not paying dividends to its shareholders.

Bio-Rad Laboratories Inc. Earnings

31 Jul 2025 (In 2 weeks) Date
1.75
Cons. EPS
-
EPS
30 Jul 2025 (In 2 weeks) Date
-
Cons. EPS
-
EPS
5 May 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
-
Cons. EPS
-
EPS
30 Oct 2024 Date
-
Cons. EPS
-
EPS
BUWA is not paying dividends to its shareholders.
31 Jul 2025 (In 2 weeks) Date
1.75
Cons. EPS
-
EPS
30 Jul 2025 (In 2 weeks) Date
-
Cons. EPS
-
EPS
5 May 2025 Date
-
Cons. EPS
-
EPS
13 Feb 2025 Date
-
Cons. EPS
-
EPS
30 Oct 2024 Date
-
Cons. EPS
-
EPS

Bio-Rad Laboratories Inc. (BUWA) FAQ

What is the stock price today?

The current price is €220.20.

On which exchange is it traded?

Bio-Rad Laboratories Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is BUWA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 9.88B.

When is the next earnings date?

The next earnings report will release on Jul 30, 2025.

Has Bio-Rad Laboratories Inc. ever had a stock split?

Bio-Rad Laboratories Inc. had 5 splits and the recent split was on Mar 08, 2002.

Bio-Rad Laboratories Inc. Profile

Medical - Devices Industry
Healthcare Sector
Norman D. Schwartz CEO
XBER Exchange
US0905722072 ISIN
US Country
7,700 Employees
- Last Dividend
8 Mar 2002 Last Split
- IPO Date

Overview

Bio-Rad Laboratories, Inc., founded in 1952 and based in Hercules, California, is a prominent provider of life science research and clinical diagnostic products globally, serving customers in the United States, Europe, Asia, Canada, and Latin America. The company operates in two key segments: Life Science and Clinical Diagnostics. With a strong commitment to innovation and quality, Bio-Rad develops, manufactures, and distributes a wide range of instruments, systems, reagents, and consumables designed to advance scientific understanding and improve healthcare outcomes. The firm distributes its offerings through a direct sales force, alongside a network of distributors, agents, brokers, and resellers, ensuring broad and effective market reach.

Products and Services

Bio-Rad Laboratories, Inc. offers a vast array of products and services tailored to meet the needs of various markets, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety, as well as clinical diagnostics.

  • Life Science Research Products:

    These include instruments, systems, reagents, and consumables for the separation, purification, characterization, and quantitation of biological materials like cells, proteins, and nucleic acids. These products support critical research areas in proteomics and genomics, empowering scientists to make groundbreaking discoveries in biology and medicine.

  • Clinical Diagnostics Products:

    Bio-Rad offers an extensive range of test systems, informatics systems, test kits, and specialized quality controls. These are designed for application in various settings including hospitals, diagnostic reference labs, transfusion services, and physician office laboratories. The clinical diagnostics segment focuses on providing accurate and reliable tools for the diagnoses of diseases and the monitoring of treatment efficacy.

  • Biopharmaceutical Production Supplies:

    This range supports the production of biopharmaceuticals with a focus on the purification and analysis of biological materials. Bio-Rad's products in this category are essential for ensuring the safety and efficacy of biopharmaceuticals, including vaccines, antibodies, and therapeutic proteins.

  • Food Safety Testing Products:

    Bio-Rad also provides robust solutions for testing the safety of food products. These include reagents, instruments, and systems that help detect potentially harmful contaminants in food, ensuring compliance with international food safety standards and protecting public health.

Contact Information

Address: 1000 Alfred Nobel Drive
Phone: 510 724 7000